10-Q: Herbalife Q3 2025: Sales Up, Profit Surges on Cost Cuts

Herbalife Ltd. reported a 2.7% increase in net sales for Q3 2025, with a significant 87.0% surge in net income for the nine-month period, driven by strategic cost reductions and pricing actions.

Summary

• Net sales for the three months ended September 30, 2025, increased by 2.7% to $1,273.7 million (3.2% in local currency) compared to the same period in 2024.
• Net sales for the nine months ended September 30, 2025, decreased by 0.8% to $3,754.5 million (increased 1.5% in local currency) compared to the same period in 2024.
• Net income attributable to Herbalife for the three months ended September 30, 2025, decreased by 8.9% to $43.2 million, resulting in diluted EPS of $0.42.
• Net income attributable to Herbalife for the nine months ended September 30, 2025, increased by 87.0% to $142.9 million, resulting in diluted EPS of $1.38.
• Operating cash flow for the nine months ended September 30, 2025, increased to $235.0 million from $215.8 million in the prior year.
• The company completed its Transformation Program as of December 31, 2024, realizing annual savings of approximately $110 million.
• The Restructuring Program was substantially completed as of December 31, 2024, and is expected to deliver annual savings of at least $80 million starting in 2025.
• Initiated a Technology Realignment Program in April 2025, with the first phase expected to deliver $9 million in annual savings starting in 2026.
• Acquired assets of Pruvit Ventures, Inc., Pro2col Health LLC, and Link BioSciences Inc. in 2025 for an aggregate of approximately $25.5 million.

Sentiment

Score: 7

Explanation: While Q3 net income saw a slight dip, the nine-month results show strong growth in net income and EPS, coupled with improved operating cash flow and a healthier balance sheet due to debt repayment and cost-saving initiatives. The company is actively investing in strategic acquisitions and digital transformation, indicating a proactive approach to future growth despite ongoing macroeconomic headwinds and sales volume declines in some key regions.

Positives

• Net sales increased by 2.7% for the three months ended September 30, 2025, and by 3.2% in local currency.
• Net income attributable to Herbalife surged by 87.0% for the nine months ended September 30, 2025, to $142.9 million.
• Diluted EPS increased by 84.0% for the nine months ended September 30, 2025, to $1.38.
• Operating cash flow improved by $19.2 million to $235.0 million for the nine months ended September 30, 2025.
• Shareholders deficit improved significantly from $(801.1) million as of December 31, 2024, to $(606.0) million as of September 30, 2025.
• Successful completion of the Transformation Program, yielding $110 million in annual savings.
• Restructuring Program expected to deliver at least $80 million in annual savings starting in 2025.
• Latin America region showed strong net sales growth of 10.9% (3 months) and 2.1% (9 months), with sales volume increases.
• Energy, Sports, and Fitness product category demonstrated robust growth of 11.6% (3 months) and 6.4% (9 months).
• Repayment of the remaining $147.3 million outstanding principal of the 2025 Notes upon maturity in September 2025, significantly reducing current portion of long-term debt.
• In compliance with all financial covenants under the 2024 Credit Facility.
• Favorable ruling from the Second Level Administrative Court regarding the 2018 India tax year case, which was subsequently closed.
• Vietnam government renewed direct selling license until January 2030.

Negatives

• Net income attributable to Herbalife decreased by 8.9% for the three months ended September 30, 2025, primarily due to higher royalty overrides and income taxes.
• Net sales for the nine months ended September 30, 2025, decreased by 0.8% (though increased 1.5% in local currency), primarily due to unfavorable foreign currency impacts and a 1.7% decrease in sales volume.
• Sales volume decreased in North America (-4.6% for 9 months), EMEA (-1.9% for 3 months, -4.1% for 9 months), Asia Pacific (-0.5% for 9 months), and China (-11.5% for 3 months, -10.4% for 9 months).
• Gross profit as a percentage of net sales decreased by 65 basis points for the three months ended September 30, 2025, due to foreign currency fluctuations, cost changes, and higher inventory write-downs.
• Cash and cash equivalents decreased from $415.3 million at December 31, 2024, to $305.5 million at September 30, 2025.
• Russia entity had no sales during the nine months ended September 30, 2025, due to the suspension of product shipments and fully depleted inventory.
• Certain markets in EMEA and Asia Pacific continue to experience adverse economic conditions, such as inflation, weakened consumer confidence, and foreign exchange rate fluctuations.
• Decline of new Members for some Asia Pacific markets.
• Higher inventory write-downs of $21.4 million for the nine months ended September 30, 2025, compared to $17.0 million in 2024.

Risks

• Potential impacts of current global economic conditions, including inflation, unfavorable foreign exchange rate fluctuations, and tariffs or retaliatory tariffs, on the company, its Members, customers, supply chain, and the world economy.
• Ability to attract and retain Members.
• Noncompliance with, or improper action by employees or Members in violation of, applicable U.S. and foreign laws, rules, and regulations.
• Adverse publicity associated with the company or the direct-selling industry, including ability to comfort the marketplace and regulators regarding compliance with applicable laws.
• Changing consumer preferences and demands and evolving industry standards, including with respect to climate change, sustainability, and other environmental, social, and governance matters.
• Legal and regulatory matters, including regulatory actions concerning, or legal challenges to, products or network marketing program and product liability claims.
• The Consent Order entered into with the Federal Trade Commission (FTC), the effects thereof and any failure to comply therewith.
• Risks associated with operating internationally and in China.
• Ability to execute growth and other strategic initiatives (such as restructuring efforts and increased market penetration in existing markets).
• The effectiveness and acceptance of new technology-driven initiatives.
• Any material disruption to business caused by natural disasters, other catastrophic events, acts of war or terrorism (including the wars in Ukraine and the Middle East), cybersecurity incidents, pandemics, and/or other acts by third parties.
• Ability to adequately source ingredients, packaging materials, and other raw materials and manufacture and distribute products.
• Reliance on information technology infrastructure, and ability to successfully develop, deploy, and integrate artificial intelligence into business.
• Noncompliance with any privacy, artificial intelligence, and data protection laws, rules, or regulations or any security breach involving the misappropriation, loss, or other unauthorized use or disclosure of confidential information.
• Contractual limitations on ability to expand or change the direct-selling business model.
• Sufficiency of trademarks and other intellectual property.
• Product concentration.
• Reliance upon, or the loss or departure of any member of, the senior management team.
• Ability to integrate and capitalize on acquisition transactions.
• Restrictions imposed by covenants in the agreements governing indebtedness.
• Risks related to convertible notes.
• Changes in, and uncertainties relating to, the application of transfer pricing, income tax, customs duties, value added taxes, and other tax laws, treaties, and regulations, or their interpretation.
• Incorporation under the laws of the Cayman Islands.
• Share price volatility related to, among other things, speculative trading and certain traders shorting common shares.

Future Outlook

The company expects total capital expenditures of approximately $80 million to $90 million for the full year 2025, including investments in the Herbalife One Digital Technology Program. Non-cash amortization expenses for Herbalife One are projected to be $40 million to $45 million for the full-year 2025 and similar amounts thereafter. The first phase of the Technology Realignment Program is expected to be completed in 2025, delivering approximately $9 million in annual savings starting in 2026, with $6 million expected in 2025. The commercial release of the Pro2col technology platform in the U.S. and Puerto Rico is planned for Q4 2025, with additional markets to follow beginning in 2026. The company intends to continue applying for government grants in China when programs are available, though there is no assurance of future grants.

Management Comments

• We believe enhanced consumer awareness and demand for our products due to global trends such as the obesity epidemic, increasing interest in a fit and active lifestyle, living healthier, and the rise of entrepreneurship, coupled with the effectiveness of personalized selling through a direct sales channel, have been the primary reasons for our continued success.
• We remain focused on the opportunities and challenges in retailing our products and enhancing the customer experience, sponsoring and retaining Members, improving Member productivity, further penetrating existing markets, globalizing successful Daily Methods of Operation, or DMOs, such as Nutrition Clubs, Fit Clubs, and Weight Loss Challenges, introducing new products and globalizing existing products, developing niche market segments and further investing in our infrastructure.
• Management uses the Marketing Plan, which reflects the rules for our global network marketing organization that specify the qualification requirements and general compensation structure for Members, coupled with educational, training, and motivational programs and promotions to encourage Members to increase retailing, retention, and recruiting, which in turn affect net sales.
• Management's strategy is to review the applicability of expanding successful country initiatives throughout a region, and where appropriate, support the globalization of these initiatives.
• We continue to examine our cost structure and assess potential incremental pricing actions in response to ongoing inflationary pressures which could impact our net sales and sales volumes.
• We expect that cash and funds provided from operations, available borrowings under the 2024 Credit Facility, and longer-term access to capital markets will provide sufficient working capital to operate our business, to make expected capital expenditures, and to meet foreseeable liquidity requirements for the next twelve months and thereafter.

Industry Context

Herbalife operates in the global nutrition and direct selling industry, which is influenced by trends such as increasing health consciousness (obesity epidemic, active lifestyles), demand for personalized nutrition, and the rise of entrepreneurship. The company's strategy of leveraging a direct sales channel with personalized selling aligns with these trends. However, the industry also faces challenges from global macroeconomic factors like inflation, foreign exchange volatility, and geopolitical conflicts, which impact cost structures, pricing, and consumer demand. The company's focus on digital transformation and new product launches (e.g., healthy lifespan supplement, MultiBurn, Pro2col platform) reflects an adaptation to evolving consumer preferences and technological advancements in the health and wellness sector. The regulatory environment, particularly in direct selling (e.g., FTC Consent Order, Vietnam regulations), continues to be a significant factor.

Corporate Governance

Legal Proceedings

• Mexican Tax Administration Service has delayed processing VAT refunds ($16.2 million asset) and issued a tax assessment for 2019 of approximately $23.8 million related to VAT rates, which the company is appealing.
• Federal Revenue Office of Brazil issued tax assessments related to withholding/contributions based on payments to Members, totaling approximately $16.4 million, which the company is litigating.
• State of São Paulo (Brazil) issued ICMS tax assessments for 2013 and 2014 totaling approximately $30.2 million and $11.2 million, respectively. The company received unfavorable decisions at the Third Level Administrative Court and is litigating at the Judicial level, providing surety bonds and letters of credit.
• State of São Paulo (Brazil) issued ICMS tax assessments for 2018, 2019, 2020, and 2021 totaling approximately $43.4 million, $27.4 million, $16.5 million, and $12.0 million, respectively. The 2018 case received a favorable ruling and was closed; 2019-2021 cases are pending at the Second Level Administrative Court.
• State of Rio de Janeiro (Brazil) issued an ICMS-ST assessment for 2016 and 2017 of approximately $6.6 million, which the company is appealing.
• Other Brazilian states issued ICMS tax assessments totaling $2.7 million.
• Indian VAT and Service Tax authorities issued assessments of approximately $11.6 million for underpaid VAT and input Service Tax credits, which the company is litigating.
• Indian income tax authorities issued assessments for fiscal years 2017, 2018, 2020, 2021, and 2022 totaling approximately $16.4 million, $15.9 million, $20.9 million, $18.4 million, and $26.0 million, respectively, which the company intends to litigate.
• Product liability claims have not been material to date.
• Lawsuit: Herbalife International of America, Inc. vs. Eastern Computer Exchange, Inc. (former technology services vendor). Verdict in favor of Herbalife for $1.5 million on fraudulent concealment claim; punitive damages trial set for June 16, 2026.
• Class action lawsuit: Sarah DeSimone v. Herbalife Ltd. et al. alleges California Labor Code violations, including misclassification of distributors as independent contractors, seeking unspecified damages.

Stakeholder Impact

• Shareholders: Positive impact from increased net income and EPS for the nine-month period, improved operating cash flow, and a stronger balance sheet (reduced deficit, lower current debt). Potential for future growth from strategic acquisitions and digital investments. Risks include share price volatility, global economic conditions, and ongoing legal/regulatory challenges.
• Employees: Impacted by restructuring initiatives (retention and separation costs), but also by investments in technology and efforts to enhance operational efficiency.
• Customers: Benefit from new product launches (e.g., healthy lifespan supplement, MultiBurn), enhanced digital platforms (Pro2col, Herbalife One), and improved customer experience initiatives.
• Distributors/Members: Supported by new product launches, training and recognition programs, targeted communications, sales incentives, and modernizing technological tools. Challenges from macroeconomic conditions (inflation, high interest rates) in some markets. Subject to FTC Consent Order and direct-selling regulations.
• Creditors: Debt refinancing in 2024 and repayment of 2025 Notes in 2025 demonstrate active debt management. Company is in compliance with debt covenants.

Next Steps

• Commercial release of the Pro2col technology platform in the U.S. and Puerto Rico planned for Q4 2025, with additional markets to follow beginning in 2026.
• Completion of the first phase of the Technology Realignment Program in 2025.
• Continue to evaluate the One Big Beautiful Bill Act (OBBBA) and monitor additional guidance issued by regulatory authorities to assess any potential impacts on condensed consolidated financial statements.
• Seek renewal of Vietnam direct selling license in January 2030.
• Trial for punitive damages in Herbalife International of America, Inc. vs. Eastern Computer Exchange, Inc. set for June 16, 2026.
• Continue to litigate various tax assessments in Mexico, Brazil, and India.

Key Dates

Recommendation

The filing presents a mixed bag of results. While the nine-month period shows strong net income and EPS growth, driven by effective cost-cutting and strategic initiatives, the quarterly net income declined. Sales volume decreases in several key regions and ongoing macroeconomic headwinds, coupled with significant legal and regulatory contingencies, introduce considerable uncertainty. The company's proactive investments in digital transformation and acquisitions are positive long-term signals, but their full impact and the resolution of various tax and legal challenges remain to be seen. Given the current environment, a 'hold' recommendation is appropriate, advising investors to monitor the execution of strategic initiatives and the resolution of legal/regulatory matters before making further investment decisions.

Keywords

Herbalife, HLF, Nutrition, Direct Selling, Multi-level Marketing, Dietary Supplements, Weight Management, SEC Filing, 10-Q, Financial Results, Earnings, Sales, Profit, Debt, Acquisitions, Global Economy, Regulatory Risk, Shareholder Deficit, Cash Flow, Digital Transformation, Pro2col, Pruvit, Link BioSciences